Zylox-Tonbridge and GL Capital invest HK$1.48B in LifeTech Scientific

Zylox-Tonbridge and GL Capital, through joint vehicle GL Lighthouse Two Investment, will invest about HK$1.482 billion ($189 million) for newly issued shares equal to about 16.7% of LifeTech Scientific's enlarged capital. Zylox-Tonbridge holds 60% of the joint vehicle and also intends to pursue a potential merger with LifeTech.

“Zylox-Tonbridge and GL Capital have announced a strategic investment in LifeTech Scientific, aimed at building an integrated vascular and structural heart intervention platform in China.”gsmedtech.com

• 1 source
• gsmedtech.comZylox-Tonbridge and GL Capital invest HK$1.48B in LifeTech Scientific | Guided SolutionsNov 10, 2026

Summarized from public sources; check the original articles before acting on it.